Article | October 5, 2022

Top 3 Trends In Cell And Gene Therapy

Source: OmniaBio
T-cells GettyImages-956478348

Thanks in part to lessons learned and trends accelerated by COVID-19, there have been many significant developments in cell and gene therapy (CGT) manufacturing. Clinical activity ramped up, and the industry is poised for rapid growth. However, there are long-standing and new challenges to overcome that can hinder this progress.

This article describes three trends will help to address current and future issues, accelerate transformations in CGT and propel the industry forward.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene